INSL3 Antikörper (AA 115-131)
Kurzübersicht für INSL3 Antikörper (AA 115-131) (ABIN2294576)
Target
Alle INSL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 115-131
-
Sequenz
- CCLSGCTQQD LLTLCPY
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo Rt
-
Produktmerkmale
- Insulin-like 3 (INSL3, Leydig Insulin-like Peptide, Ley I-L, MGC119818, MGC119819, Relaxin-like Factor, RLF, RLNL)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic peptide corresponding to aa115-131, CCLSGCTQQDLLTLCPY near the C-terminal of human INSL3. Species sequence homology: rat and mouse, three amino acids difference.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 200 μL sterile ddH2O.
-
Buffer
- Supplied as a lyophilized powder from PBS, 5 % BSA, 0.05 % thimerosal, 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- INSL3 (Insulin-Like 3 (Leydig Cell) (INSL3))
-
Andere Bezeichnung
- Insulin-Like 3
-
Pathways
- Hormone Activity, cAMP Metabolic Process
Target
-